{
  "id": 16626292,
  "title": "Baby Aspirin Misses Mark for Primary Cardiovascular Prevention in CKD",
  "url": "https://urgent.news/2026/10/26/baby-aspirin-misses-mark-for-primary-cardiovascular-prevention-in-ckd",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T15:53:07.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/asn/123579"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- DENVER -- Daily low-dose aspirin did not significantly reduce major vascular events in adults with chronic kidney disease (CKD), the randomized ATTACK trial showed. Over a mean follow-up of 3.1 years, 2.4% of adults with CKD...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}